Company Filing History:
Years Active: 2012-2015
Title: The Innovative Contributions of Selvaraj Mohane Coumar
Introduction
Selvaraj Mohane Coumar is a distinguished inventor based in Pondicherry, India. He has made significant contributions to the field of medicinal chemistry, particularly in the development of compounds that target protein kinases. With a total of 3 patents to his name, Coumar's work is paving the way for new treatments in cancer therapy.
Latest Patents
Coumar's latest patents include groundbreaking research on fused multicyclic compounds as protein kinase inhibitors. These compounds are designed to inhibit protein kinase activity, specifically targeting Aurora kinase, which plays a crucial role in cancer progression. Another notable patent involves fused bicyclic and tricyclic pyrimidine compounds as tyrosine kinase inhibitors. These compounds aim to inhibit EGFR kinase activity, providing a method for treating various forms of cancer.
Career Highlights
Selvaraj Mohane Coumar is currently affiliated with the National Health Research Institutes, where he continues to advance his research in the field of cancer therapeutics. His innovative approach to drug design has garnered attention in the scientific community, contributing to the ongoing fight against cancer.
Collaborations
Coumar has collaborated with esteemed colleagues such as Hsing-Pang Hsieh and Yu-Sheng Chao. These partnerships have enhanced the scope and impact of his research, leading to significant advancements in the development of effective cancer treatments.
Conclusion
Selvaraj Mohane Coumar's contributions to medicinal chemistry and cancer research are noteworthy. His innovative patents and collaborations reflect his commitment to improving therapeutic options for patients. The impact of his work is expected to resonate in the field for years to come.